Csf1r mRNA in adult mice is expressed in cells of the macrophage lineage, and during development, it is also expressed from a separate promoter in placental trophoblast cells. This mouse trophoblast promoter sequence is conserved across species, but human trophoblasts actually initiate transcription from a separate promoter 20 kb upstream, which is not conserved in rodents. A 7.2-kb fragment of the mouse Csf1r genomic DNA, including the 3.5-kb promoter, the first coding exon and downstream intron, is sufficient to direct reproducible position-and copy number-independent expression of an EGFP reporter in vitro and in vivo. In this study, we have examined the consequence of removal of the 150-bp fragment encompassing the conserved trophoblast promoter region in the context of the 7.2-kb promoter on reporter gene expression in transgenic mice. The deletion ablated expression in the placenta but also abolished expression in multinucleated OCL and reduced expression in macrophages. RT-PCR analyses of Csf1r mRNA revealed that mouse OCL use another promoter within this region, distinct from that used in placental trophoblasts, to generate an alternative 5ЈUTR.
Introduction
CSF-1 (M-CSF) is necessary for the proliferation, differentiation, and survival of cells of the mononuclear phagocyte lineage [1] [2] [3] . CSF-1 acts on its target cells through the CSF-1R, a class III receptor tyrosine kinase encoded by the c-fms protooncogene. The Csf1r gene is transcribed early in myeloid lineage commitment, and its expression increases as cells differentiate toward mature macrophages [1] . CSF1R is also expressed in multinucleated OCL, and their precursors and mutation of the CSF-1, or its receptor, gene in mice or rats lead to OCL deficiency and osteopetrosis [2] . During embryonic development, Csf1r is expressed in another cell type-the giant trophoblast cells. This expression is driven by a separate promoter; in humans, this promoter lies within the 3ЈUTR of the upstream platelet-derived growth factor receptor-␤ gene, whereas in mice, the major trophoblast-specific promoter resides within a 150-bp region approximately 200 bp upstream of the major macrophage promoter [4] , that is conserved across mammalian species (see Fig. 1 ). We have studied the control of the Csf1r gene to understand the process of macrophage differentiation at a transcriptional level [1, [5] [6] [7] [8] . The Csf1r transcript in macrophages is expressed from a purine-rich promoter that lacks a TATA box and other classical elements that specify the transcription initiation site. The proximal promoter of Csf1r alone is not sufficient to generate high-level expression. A highly conserved 300-bp sequence in the first intron downstream of the macrophage promoter, the FIRE, was needed to provide position-and copy number-independent expression of a Csf1r promoter-EGFP reporter construct [4] . The Csf1r promoter has been used in a range of applications to generate macrophage-specific gene expression (e.g., refs. [9, 10] ). However, the possible expression in giant trophoblast cells is a constraint in the interpretation of phenotypes generated in some transgenic animals. Thus, we sought to remove the trophoblast-specific promoter. A secondary aim was to provide a plausible explanation for the high conservation of this region across mammalian species (see Fig. 1 ), despite the fact that humans do not use this region to direct expression in trophoblast cells; furthermore, the upstream human-specific trophoblast promoter is not conserved at all in mice [1] .
MATERIALS AND METHODS

Plasmids, cell culture, and transfection
Bone marrow cells were isolated from the femurs of adult mice and cultured in RPMI-1640 medium containing penicillin, streptomycin, and 10% low-endotoxin FBS (Gibco/Invitrogen, San Diego, CA, USA). Cells were differentiated into macrophages by a 5-to 7-day treatment with 1000 units/ml human rCSF-1 (a gift from Chiron Corp., Emeryville, CA, USA). OCL were produced by differentiating primary mouse bone marrow cells or RAW264/C4 cells in DMEM in the presence of 40 ng/ml mouse rRANKL and with the above supplements (including CSF-1), except for the use of SerumSupreme instead of FBS for 7 days (see ref. [11] ). PCR spliceoverlap mutagenesis was used to introduce a deletion of nucleotides -454 to -298 (relative to the Csf1r ATG) containing the putative trophoblastspecific promoter in the context of the well-characterized Csf1r 7.2 kb promoter (GenBank Accession Number AF290879 with the Csf1r ATG mutated, as described in ref. [4] ), as described previously [10] . To generate the Csf1r(⌬ tro )-EGFP plasmid, the deleted promoter was subcloned in place of the full-length promoter used previously in the Csf1r-EGFP plasmid [4, 10] . The constructs and bases removed are highlighted (see Fig. 2 ).
Transgenic animals
A transgene construct containing the Csf1r(⌬ tro ) promoter, EGFP open-reading frame, and a polydenylation signal was excised using MluI and SalI digestion and purified from the plasmid backbone (see Fig. 2A ). The fragment was then used at a concentration of 4 ng/l for pronuclear injection of the C57Bl6/JxCBA F2 mouse zygotes for transgenic line establishment using standard protocols, carried out by the Transgenic Animal Service of Queensland facility (University of Queensland, Australia; http://tasq. uq.edu.au).
Localization of EGFP
Analysis of EGFP expression in tissues of transgenic mice was performed as described previously [4] . Briefly, paraformaldehyde-fixed tissues were cryopreserved using the Optimal Cutting Temperature compound (Sakura Finetek, Japan) and cryosectioned at 10 m. Mounted slides and cells expressing EGFP were visualized using an Olympus IX-70 inverted microscope and FITC (530/30) filter set. Antibodies used for FACS analysis were: anti-F4/80-R-PE (Serotec, Oxford, UK), anti-Ly6G-R-PE (BD PharMingen, San Diego, CA, USA), or rat anti-mouse Csf1r IgG 2a (from the hybridoma AFS98 provided by Dr. S. Nishikawa, Kyoto University, Kyoto, Japan), followed by PE-conjugated anti-rat IgG F(abЈ) 2 fragments.
RNA isolation and RT-PCR analysis
Total RNA was prepared from 10 6 cells (RAW264/C4 or bone marrow-OCL, cultured as above) using the Qiagen (Germany) RNeasy mini kit, as per the manufacturer's instructions. Total RNA (3 g) was used for RT reaction carried out using oligo(dT) 20 priming and SuperScriptIII RT (Gibco/Invitrogen), as per the manufacturer's instructions. RT-PCR was performed using f1.1 and r2 or f1.2 and r2 primer sets using the following conditions: 2 min at 95°C; 25ϫ (30 min at 95°C, 45 s at 58°C, 45 s at 72°C); 3 min at 72°C. PCR products were separated on a 1.8% Tris/acetate/EDTA agarose gel. Primers used were: f1.1 5Ј-tgactcctctcctaagtgtcc; f1.2 5Ј-gccccagattctgcctcttcc; r2 5Ј-accagaggaggccccaactcc.
RESULTS AND DISCUSSION
Sequence conservation of the trophoblast promoter region of the mouse Csf1r gene and its activity in transfection assays
Trophoblast-specific expression of Csf1r in mice involves multiple start sites that generate a number of alternative 5Ј noncoding exons with distinct splice donors, each of which splices into one of two splice acceptors [4] (also, see Fig. 5 below) . In humans, the 5Ј trophoblast-specific exon that splices into the first coding exon is located 20 kb upstream [4] . For the purpose of this study, we have defined the mouse trophoblast promoter region as a 150-bp region that encompasses the major TSS identified previously [4] . Figure 1 shows a ClustalW alignment of the 150-bp trophoblast promoter region highlighting conserved elements across a wide range of mammalian species. Candidate transcription factor-binding sites were identified using the Transcription Element Search System server at http://www.cbil.upenn.edu/cgi-bin/tess. One prominent feature of the region is an alternating pattern of pyrimidine-and purine-rich tracts, which include multiple inverted repeats.
In transient transfections, a 500-bp mouse Csf1r proximal promoter construct was active in RAW264.7 cells. Deletion of the trophoblast promoter region, between -500 and -200 of the ATG, had little effect on the expression of a luciferase reporter gene [5] . However, an indication of possible functional activity was evident from the fact that the same region was absolutely required for the growth factor-dependent ectopic activity of the promoter in a wide range of mouse tumor cell lines that do not express full-length Csf1r mRNA [5] . The Csf1r intron 1 contains a transcriptional terminator so that an intron-containing reporter gene is much less active than the promoter alone, even in RAW264.7 cells, and completely inactive in nonmacrophage cell lines [4] . We investigated whether the trophoblast promoter might have a function in macrophages that is only evident in the context of the longer construct, containing the FIRE intronic enhancer used in the MacGreen mouse. Accordingly, we deleted the 150-bp region from -454 to -298 within the 7.2-kb Csf1r promoter and produced luciferase and EGFP reporter plasmids. The constructs used are diagrammatically shown in Figure 2A , the precise sequence deleted, and its position relative to the macrophage TSS in Figure 2B . We tested the effect of the 150-bp deletion on 7.2 kb Csf1r promoter activity in transient and stable transfections of RAW264.7 cells with EGFP and luciferase reporters. Consistent with the lack of impact described previously [5] on the basal promoter activity of removal of the region upstream of -300 bp, we found no difference in activity between intact and deleted promoters (data not shown). However, Csf1r mRNA is expressed at a low level in RAW264.7 cells at the level of primary macrophages in the presence of CSF-1 (this is evident in a direct comparison on microarrays; see www.biogps.org), where the gene is transcriptionally down-regulated [6] . So, the lack of effect of the deletion in RAW264.7 cells does not necessarily predict the possible role of the element in mature macrophages.
Generation of transgenic lines expressing EGFP from a mutated Csf1r promoter
The intact Csf1r-EGFP transgene was expressed in all tissue macrophages and dendritic cells in the MacGreen mouse [4] . In a separate study, we used the Csf1r promoter with the 150-bp trophoblast start region removed to drive expression of a Gal4-VP16 artificial transcription factor transgene with a cointegrated Gal4-responsive UAS-ECFP reporter. The resulting MacBlue mice expressed ECFP in all tissue macrophages, but there was no detectable expression in trophoblasts [10] . In MacGreen mice, the intact promoter directs reporter gene expression in granulocytes (which express Csf1r mRNA, although they do not translate the protein [12] ), but in the MacBlue mice, granulocyte expression was reduced greatly (to Ͻ3% [5] ).
One way of approaching the function of the trophoblast promoter would be to delete it in the germ line, but if it did have an effect on Csf1r expression, we would compromise trophoblast or macrophage production. So, the only alternative approach to determining the function of the trophoblast promoter region is to delete it in the context of an EGFP reporter line (as we did previously with FIRE [4] ) and determine the effect by examining multiple independent transgenic lines.
Accordingly, we produced five independent transgenic lines using the deleted Csf1r promoter construct (shown in Fig. 2A ) and compared them with the MacGreen line, which is, in turn, representative of multiple independent lines analyzed previously [4] .
Expression of the EGFP reporter in myeloid cells of Csf1r(⌬tro)-EGFP transgenic mouse lines
The expression of EGFP in the individual transgenic lines was more variable than in the original Csf1r-EGFP (MacGreen) transgenic lines. In the MacGreen mice, EGFP was detected readily in the placental trophoblasts [4] . Confirming the impact of the deletion seen in the MacBlue mice [10] , in each of the Csf1r(⌬tro)-EGFP lines, reporter gene expression was ablated in the placenta.
Four of five of the Csf1r(⌬tro)-EGFP lines also expressed EGFP in cells of bone marrow and peripheral blood. Figure 3 compares the EGFP expression profiles of the five lines with the MacGreen line in bone marrow. By contrast to the MacBlue transgenic line, all but one of the lines expressed detectable EGFP in the granulocyte fraction (detected with the Ly6G surface marker [12] ), suggesting that the apparent absence of expression of ECFP in granulocytes of MacBlue mice [10, 12] is partly a function of the binary Gal4-UAS system rather than the specificity of the deleted promoter. However, even in the highest expressing lines (e.g., Lines 1 and 2), the The sequences from each of the species were identified from Ensembl (www.ensembl.org). Alignment of the proximal promoter region was performed using the ClustalW algorithm; selected conserved transcription factor-binding sites with particular relevance to myeloid or OCL biology were identified using Transfac. The final nucleotide (G) of the 150-bp trophoblast promoter region is marked with a black arrowhead. GR, Glucocorticoid receptor; VDR, vitamin D receptor; YY1, ying-yang 1; ER-␣, estrogen receptor ␣.
median EGFP intensity in the Ly6G-positive cells was lower compared with MacGreen control (Fig. 3A) , suggesting that the elements within the deleted 150-bp region contribute to maximal expression in granulocytes. In the Ly6G-negative bone marrow fraction of the MacGreen control mice, representing monocytes and their precursors, there are two clear populations of EGFP-positive cells. In the two higher-expressing lines (1 and 2), the EGFP high population was not detected, and in the other three lines, expression in all of the monocytes was greatly reduced.
In peripheral blood of the MacGreen mice (Fig. 3B ), two cell populations with different levels of EGFP expression were also evident within the F4/80-positive monocyte population. The EGFP high cells, which also have higher average F4/80 levels [4] and lack expression of Ly6C (not shown), correspond to the so-called resident monocyte population [13, 14] . In all four of the expressing lines, the EGFP distribution of monocytes was shifted to the left, so that the presumptive "inflammatory" F4/80 low monocyte population was EGFP-negative. Figure 3 , C and D, shows the expression of the transgene in TEPM. EGFP was detected in two clearly distinguishable populations, both of which coexpressed the macrophage marker F4/80 and surface CSF1R. In three of the four lines, as in the bone marrow, this binary distribution was lost, and all of the F4/80-positive cells expressed relatively low EGFP, and EGFP expression in the TEPM of MacGreen mice did not correlate with detection of surface CSF1R; not surprisingly, TEPM are autocrine for CSF-1, and the surface receptor is regulated by ligand [15] . Nevertheless, the CSF1R-positive elicited macrophages showed the same bimodal distribution of EGFP expression, and in all four lines, the EGFP high fraction appeared to be selectively lost. Taken together, the data suggest that the upstream region is involved in some way in increased expression of Csf1r during maturation of cells of the macrophage and granulocyte lineages.
Deletion of the trophoblast promoter region of the Csf1r-EGFP transgene ablates EGFP reporter expression in multinucleated OCL
As noted in the introduction, Csf1r expression is required for normal osteoclastogenesis. We were therefore surprised to note that in the Csf1r(⌬tro)-EGFP and the MacBlue mice, expression of the reporter gene was completely absent from OCL in sections of bone (not shown). In the MacGreen mice, surfaces of bone are covered with an EGFP-positive macrophage population that contributes to the regulation of osteoblast function [16] . The modified reporter gene provides a possible way to distinguish these cells from OCL in functional studies. We therefore extended the observation by cultivating bone marrow cells from each of the transgenic lines in the presence of CSF-1 and RANKL to promote osteoclastogenesis. Figure 4 shows a comparison of typical cultures from each of the lines. Whereas EGFP is expressed in OCLs in MacGreen mice, the 150-bp deletion selectively abolished expression in multinucleated OCL in every case, including the MacBlue mice. Although the surrounding CSF-1-dependent macrophages were clearly EGFP-positive, forming oligonuclear OCL already demonstrated a significant decrease in EGFP levels in all but MacGreen transgenic lines (arrows in Fig. 4) .
Given the complete ablation of EGFP expression in OCL in Csf1r(tro)-EGFP transgenic lines, by contrast to the strong expression in the CSF-1-dependent macrophages in the same cultures (Fig. 4) , we considered the possibility that OCL lineage divergence involves a switch to using the trophoblast promoter. To address this possibility, we examined the 5Ј ends of Csf1r mRNAs expressed by a subclone of the RAW264.7 cell Fig. 1 ) is underlined by a red line, and the blue line highlights the region encompassing most of macrophage-specific TSS of the mouse Csf1r gene [4] . line selected for its ability to produce OCL in the presence of RANKL [11] . As shown in Figure 5 , RAW264/C4 cells driven toward the OCL lineage did indeed use a separate set of promoters with a complex set of alternative 5ЈUTRs generated through splicing into two alternative acceptors. Our previous studies demonstrated that mouse trophoblasts produce a series of transcripts from multiple start sites, and most such transcripts are spliced into two alternative splice acceptors [4] . Figure 5 . Analysis of transcription originating from the Csf1r promoter in differentiating OCL. RAW264/C4 (RAW/C4) cells were cultivated in medium with CSF-1 and RANKL to promote OCL differentiation for the times indicated, and RNA was extracted and subjected to RT-PCR analysis to identify transcripts initiating from the upstream promoter region shown in Figures 1 and 2 . The diagram shows the predicted frequency of TSS use for cells of the trophoblast lineage (represented by the height of gray triangles; adapted from ref. [4] , based on the available Expressed Sequence Tags and 5Ј RACE data). RT-PCR products in the RAW264/C4 cells confirm the presence of splice forms originating from the more proximal TSS (amplified using the f1.2 primer, black triangles). No transcripts were detected using the f1.1 primer, which should detect the majority of transcripts produced in trophoblasts. Relevant position values of exon boundaries are shown relative to the Csf1r translation start codon. The dominant Csf1r transcript induced during an efficient OCL differentiation of RAW264/C4 cells was actually the largest, unspliced form, generating an extended 5ЈUTR that contains the entire conserved region flanking the first coding exon of Csf1r. The extended OCL-specific transcripts were also detected in primary bone marrow-derived OCL grown in CSF-1 and RANKL but were more difficult to detect and quantify against the dominant background of the macrophages that form the majority of cells in such cultures, as evident in Figure  4 . These data show that OCL initiate transcription within the 150-bp trophoblast promoter region but use distinct TSS and distinct splicing patterns.
Implications for the study of macrophage and OCL biology
This study has demonstrated that the conserved distal promoter region of the mammalian Csf1r promoter highlighted in Figure 1 has at least four separate activities-as a promoter in trophoblasts of the mouse, as a separate promoter for OCL, as the 5ЈUTR of Csf1r mRNA produced in OCL, and as a regulatory element that increases the expression of the gene during macrophage (and granulocyte) differentiation. The last three activities mean that the transgenic reporter lines produced using the deleted Csf1r promoter, especially the MacBlue line, have a novel and unexpected, potential use in studies of macrophage and OCL lineage divergence. For the macrophages, it appears that the upstream region contributes elements that are required for the progressive increase in expression of the reporter gene in the so-called resident monocyte subset (reviewed in refs. [16 -18] ) and in resident tissue macrophages. Expression from the corresponding, intact Csf1r promoter in MacGreen mice is remarkably position-and copy number-independent, and the particular MacGreen line that we have used as a comparator herein is representative of the five lines made previously [4] . The change in the pattern of EGFP reporter gene expression (as well as the overall level) shown in the various monocyte populations in Figure 3 argues further that it is the 150-bp deletion rather than the copy number or position of the transgene that reduced reporter expression in macrophages and granulocytes. This in turn suggests that the conservation of these distal elements of the promoter across species is in part a reflection of their function in the increased Csf1r expression that occurs during macrophage maturation [1, 2] .
The complete loss of expression of EGFP in OCL seen in all of the transgenics is even less likely to be a result of idiosyncrasies of insertion or copy number. The bone marrow-derived macrophages and presumptive mononuclear OCL progenitors in the same cultures are clearly, strongly EGFP-positive, suggesting that the reporter gene is extinguished upon fusion (Fig. 4) . In extensive analysis of primary macrophage transcription initiation using genome-scale 5ЈRACE (Cap Analysis of Gene Expression) in the FANTOM3 project, we did not see any initiation of transcription from this upstream promoter (see data at fantom.gsc.riken.jp). By contrast, the RAW264/C4 subclone initiated transcription from the upstream promoter even in the absence of CSF-1 and RANKL (Fig. 5) , which may be an indication of the selection for an ability to form OCL [11] . We have not tested whether the parent line shares this ability.
The OCL must have a quite distinct regulation of Csf1r transcription, as in macrophages, expression is down-regulated by LPS [1, 6] , an activator of NF-B, and the RANKL actually induced Csf1r in RAW264/C4 cells and promoted the use of the distal promoter (Fig. 5) . The use by macrophages and OCL of separate TSS within a short genomic interval mirrors our previous study of the shared promoter of the tartrate-resistant acid phosphatase gene, wherein macrophages and OCL use distinct start sites less than 50 bp apart [19] . As the two cell types-macrophages and OCL-clearly share dependence of certain transcription factors in common, notably PU.1, it may be that this proximal architecture allows a degree of sharing: each cell type using elements of the neighboring promoter as enhancers. So, PU.1, C/EBP, and AML1 bound to the downstream macrophage promoter of Csf1r (and to FIRE; see refs. [1, 6 -8] ) may still be required to allow maximal expression of Csf1r in OCL. This conclusion begs the question of exactly what factors are bound to the OCL promoter region that determine OCL specificity and contribute to elevated expression in mature macrophages. One candidate is AP1, as there is at least one highly conserved AP1 site in this region (Fig. 1) , and AP1 has been implicated in RANKL-induced expression of OCL-specific genes [20] . Another is the MITF family, acting through the E-box motif highlighted in Figure 1 . MITF is able to activate a range of OCL-specific genes in the RAW264/C4 subclone [20] . It may also be that the alternative 5ЈUTR, present in the major form of the Csf1r transcript in OCL, has some functional significance in mRNA trafficking in the large, multinucleated cell or in translation or mRNA stability.
Although the level of expression is reduced in mature macrophages, the deleted Csf1r(⌬tro) promoter construct may still be valuable for driving expression solely in subsets of monocytes and excluding trophoblasts and OCL. It will also be of interest to determine whether the expression of the transgene (Figs. 3 and 4 ) defines a subset of monocytes and macrophages with defined characteristics. 
